Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Dec 03, 2018 12:10pm

80 Views

Post# 29054651

RE:RE:Nasdaq

More precisely, IBB is up 3.47% on the Nasdaq YTD.

Market conditions affect all stocks.

bfw

SPCEO1 wrote: I assume you are talking YTD returns. Both THERF and NASDAQ are up about 7% YTD. TH, however, is up 11.6% , the difference with THERF being the weak Cnadian currency (which actually helps THERF's sales and profits).

Bucknelly21 wrote: So nasdaq up almost 7% as of now and therf down, I just have a hard time with the argument that the market conditions really move this stock. I realize we are not on the nasdaq but that seems to be the constant argument to defend the unrealistic share price that we have